We are delighted Airglove has been selected for a National Case Study by Health Innovation East.

Patients presenting with difficult intravenous access (DIVA) has been the subject of over 100 clinical studies in the past decade (1), Cannulation (accessing a vein for medical reasons) is performed 32 million times a year in the UK (8,767 a day) and over 1.2 billion a year globally (2,3,4,5).
Airglove®, now in use in over 140 NHS hospitals, reduces failure rates associated with cannulation. A budget impact analysis shows that over three years its adoption could save the NHS over £31.1m in Oncology alone. “As the Clinical Research Oncology Nurse Manager at a large teaching hospital in Scotland I am impressed with the results we have had when using the Airglove on our oncology patients … we now use the machines in our oncology department without standing results”.

For Full report Click here